Journal article
The magnitude and trend of artemether-lumefantrine stock-outs at public health facilities in Kenya.
- Abstract:
- BACKGROUND: Health facility stock-outs of artemether-lumefantrine (AL), the common first-line therapy for uncomplicated malaria across Africa, adversely affect effective malaria case-management. They have been previously reported on various scales in time and space, however the magnitude of the problem and trends over time are less clear. Here, 2010-2011 data are reported from public facilities in Kenya where alarming stock-outs were revealed in 2008. METHODS: Data were collected between January 2010 and June 2011 as part of 18 monthly cross-sectional surveys undertaken at nationally representative samples of public health facilities. The primary monitoring indicator was total stock-out of all four weight-specific AL packs. The secondary indicators were stock-outs of at least one AL pack and individual stock-outs for each AL pack. Monthly proportions and summary means of the proportions over the monitoring period were measured for each indicator. Stock-out trends were assessed using linear regression. RESULTS: The number of surveyed facilities across 18 time points ranged between 162 and 176 facilities. The stock-out means of the proportion of health facilities were 11.6% for total AL stock-out, 40.6% for stock-out of at least one AL pack, and between 20.5% and 27.4% for stock-outs of individual AL packs. Monthly decrease of the total AL stock-out was 0.005% (95% CI: -0.5 to +0.5; p = 0.983). Monthly decrease in the stock-out of at least one AL pack was 0.7% (95% CI: -1.5 to +0.3; p = 0.058) while stock-outs of individual AL packs decreased monthly between 0.2% for AL 24-pack and 0.7% for AL six-pack without statistical significance for any of the weight-specific packs. CONCLUSIONS: Despite lower levels of AL stock-outs compared to the reports in 2008, the stock-outs at Kenyan facilities during 2010-2011 are still substantial and of particular worry for the most detrimental:- simultaneous absence of any AL pack. Only minor decrease was observed in the stock-outs of individual AL packs. Recently launched interventions to eliminate AL stock-outs in Kenya are fully justified.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 423.9KB, Terms of use)
-
- Publisher copy:
- 10.1186/1475-2875-11-37
Authors
+ Medicines for Malaria Venture
More from this funder
- Funding agency for:
- Zurovac, D
- Grant:
- 092654/Z/10/A
+ Wellcome Trust
More from this funder
- Funding agency for:
- Snow, R
- Zurovac, D
- Grant:
- 092654/Z/10/A
- 092654/Z/10/A
- Publisher:
- BioMed Central
- Journal:
- Malaria journal More from this journal
- Volume:
- 11
- Issue:
- 1
- Article number:
- 37
- Publication date:
- 2012-01-01
- DOI:
- EISSN:
-
1475-2875
- ISSN:
-
1475-2875
- Language:
-
English
- Keywords:
- UUID:
-
uuid:e9da57c0-9c3d-4a8d-a2a9-e49580cbea5a
- Local pid:
-
pubs:254272
- Source identifiers:
-
254272
- Deposit date:
-
2012-12-19
Terms of use
- Copyright holder:
- Sudoi et al
- Copyright date:
- 2012
- Notes:
- © 2012 Sudoi et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record